Witryna24 cze 2024 · Glaucoma not adequately controlled by one to four different topical hypotensive medication(s), given each for at least one month, as confirmed by 21mmHg < IOP < 35 mmHg in the study eye at baseline visit. ... iSTAR Medical: ClinicalTrials.gov Identifier: NCT03996200 Other Study ID Numbers: STAR-III (ISM08) First Posted: … Witryna14 paź 2024 · The aim of this study was to evaluate in vivo (in rabbits) the ocular biocompatibility and tissue integration of a novel suprachoroidal microinvasive glaucoma implant, MINIject™ (iSTAR Medical, Wavre, Belgium). Results: In two rabbit studies, no biocompatibility issue was induced by the suprachoroidal, ab-externo …
iSTAR Medical
Witryna8 cze 2024 · MINIject ® is iSTAR Medical’s innovative MIGS device for patients with primary open-angle glaucoma. MINIject ® combines the distinctive porous structure of its proprietary STAR material with ... WitrynaiSTAR Medical is a medtech company committed to delivering breakthrough eye care solutions through minimally-invasive implants designed for bio-integration. Our mission is to become the world leader in minimally invasive implants for … MINIject ® is iSTAR Medical’s innovative minimally-invasive glaucoma surgery … Risk factors for Glaucoma . Risk factors for primary open-angle glaucoma, the most … Latest news from iSTAR Medical including press releases, events, general news … MINIject® is iSTAR Medical’s most advanced product, and is approved in … Join the team at iSTAR Medical! We are seeking talented individuals to join our … About glaucoma . Glaucoma surgery & treatments . Latest news . Press … 1 Data on file and presented by CEO Michel Vanbrabant at Ophthalmology … 2024. Perzia B, Vold S.D. “Suprachoroidal Devices in Glaucoma Therapy“, … ulearnbly
AbbVie and iSTAR Medical Announce Strategic Alliance for the …
Witryna15 mar 2024 · iSTAR Medical today announced that the first patients have been implanted in its STAR-VI international trial evaluating the safety and efficacy of the MIGS implant (MINIject) in conjunction with cataract surgery in patients with primary open-angle glaucoma. According to a news release, iSTAR Medical’s STAR-VI trial is a … Witryna20 lip 2024 · Jul 20, 2024, 07:00 ET. - Alliance will provide opportunity for AbbVie to further expand its diverse eye care portfolio and provide additional treatment options … Witryna16 lis 2024 · WAVRE, Belgium, Nov. 16, 2024 /PRNewswire/ --: iSTAR Medical, a medtech company developing minimally invasive ophthalmic implants for treatment of … thomson 32fs6646